(SeeNews) - May 8, 2012 - US biofuel and biotechnology firm Solazyme (NASDAQ:SZYM) on Monday said its net loss expanded to USD 16.8 million (12.9m) for the first quarter of 2012 from a loss of USD 7.3 million a year ago, hit by a surge in expenses.